Virtual Medicinal Product (VMP) - Co-amilofruse 1.25mg/10mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amilofruse 1.25mg/10mg/5ml oral suspension | Start Date 15-08-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- C03EB01
- BNF Codes
-
- BNF code 02020400
| Code | Start Date | End Date |
|---|---|---|
| 11814411000001102 | 15-08-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amiloride hydrochloride | Based on Ingredient Substance | 250 microgram | 1 ml | |
| Furosemide | Based on Ingredient Substance | 2 mg | 1 ml |
Name
Amiloride hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
250.0
Strength and UOM (Dmr)
1.0
Name
Furosemide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-amilofruse
-
VMP(Current) Co-amilofruse 1.25mg/10mg/5ml oral s...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |